BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 5122538)

  • 1. [Histomorphologic and histochemical changes in the skin during the treatment of scleroderma].
    Sych LI; Trofimova LIa
    Vestn Dermatol Venerol; 1971; 45(3):22-6. PubMed ID: 5122538
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of scleroderma with depolymerizing agents].
    Konopík J; Krs V
    Cas Lek Cesk; 1982 Nov; 121(44):1368-72. PubMed ID: 7172189
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dynamics of hydroxyproline content as the indicator of the severity of the course and the effectiveness of treatment of focal scleroderma].
    Fedorova EG; Lashmanova AP
    Vestn Dermatol Venerol; 1978 Dec; (12):18-22. PubMed ID: 570330
    [No Abstract]   [Full Text] [Related]  

  • 4. [Observations of the course of scleroderma after combined Hylase-carnitine therapy].
    Nitzschner H
    Z Arztl Fortbild (Jena); 1975 Nov; 69(21):1108. PubMed ID: 1226844
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment with hyaluronidase in dermatology].
    Wozniak KD; Braun W
    Z Arztl Fortbild (Jena); 1975 Nov; 69(21):1109-10. PubMed ID: 1226845
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic effectiveness of ultrasonics and lidase phonophoresis in various forms of scleroderma].
    Didenko IG
    Vestn Dermatol Venerol; 1978 Jun; (6):76-9. PubMed ID: 354249
    [No Abstract]   [Full Text] [Related]  

  • 7. Localized and systemic scleroderma show different histological responses to methotrexate therapy.
    Seyger MM; van den Hoogen FH; van Vlijmen-Willems IM; van de Kerkhof PC; de Jong EM
    J Pathol; 2001 Apr; 193(4):511-6. PubMed ID: 11276011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Morphological changes in the skin in scleroderma in the process of treatment with unithiol].
    Dubinskiĭ AA; Tseraidis GS; Guĭda PP; Petrusenko EA; Babykina EA
    Vrach Delo; 1978 Oct; (10):112-4. PubMed ID: 716343
    [No Abstract]   [Full Text] [Related]  

  • 9. [Initial results of high-dosage hyaluromidase long-term therapy ("Hylase" Dessau) in dermatology].
    Wozniak KD; Braun W
    Dtsch Gesundheitsw; 1972 Jun; 27(22):1046-8. PubMed ID: 4557763
    [No Abstract]   [Full Text] [Related]  

  • 10. [Histochemical investigations in scleroderma (author's transl)].
    Kreysel HW; Brügge P; Jänner M; Kimmig J
    MMW Munch Med Wochenschr; 1976 Sep; 118(39):1235-40. PubMed ID: 135207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of scleroderma].
    Wüthrich B
    Schweiz Rundsch Med Prax; 1973 Sep; 62(38):1149-55. PubMed ID: 4148265
    [No Abstract]   [Full Text] [Related]  

  • 12. Salazopyrin (azulfidine) treatment in scleroderma.
    Dover N
    Isr J Med Sci; 1971 Nov; 7(11):1301-3. PubMed ID: 4400695
    [No Abstract]   [Full Text] [Related]  

  • 13. [Trafuril reaction in scleroderma].
    Urban J
    Przegl Dermatol; 1976; (6 Suppl):367-9. PubMed ID: 1032188
    [No Abstract]   [Full Text] [Related]  

  • 14. Avocado/soybean unsaponifiables in the treatment of scleroderma: comment on the article by Maheu et al.
    Jablonska S
    Arthritis Rheum; 1998 Sep; 41(9):1705. PubMed ID: 9751109
    [No Abstract]   [Full Text] [Related]  

  • 15. [Histochemical changes in the skin in focal scleroderma under the effects of vitamin B 15 therapy].
    Strukov AI; Rakhmanov VA; Shakhtmeĭster IIa; Kop'eva TN; Matiashevich RG; Azhgikhin IS
    Vestn Dermatol Venerol; 1969 Sep; 43(9):12-9. PubMed ID: 5387300
    [No Abstract]   [Full Text] [Related]  

  • 16. [Histological distinction between progressive and circumscript scleroderma].
    Ishikawa H; Mori S
    Hautarzt; 1972 Sep; 23(9):404-9. PubMed ID: 4264853
    [No Abstract]   [Full Text] [Related]  

  • 17. [Madecassol in the treatment of scleroderma (preliminary study)].
    Szczepański A; Dabrowska H; Blaszczyk M
    Przegl Dermatol; 1974; 61(5):701-3. PubMed ID: 4419170
    [No Abstract]   [Full Text] [Related]  

  • 18. [Piascledine in the treatment of scleroderma].
    Szczepański A; Dabrowska H; Moskalewska K
    Przegl Dermatol; 1974; 61(4):525-7. PubMed ID: 4849404
    [No Abstract]   [Full Text] [Related]  

  • 19. [Proteolytic enzyme, trypsin, in therapy of patients with scleroderma].
    Dovzhanskiĭ SI; Slesarenko NA
    Vestn Dermatol Venerol; 1977 Aug; (8):56-8. PubMed ID: 930311
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of piascledine treatment of scleroderma].
    Szczepański A; Dabrowska H; Moskalewska K
    Przegl Dermatol; 1975; 62(4):555-8. PubMed ID: 1162105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.